musculoskeletal, oncological or psychological diseases, post-COVID-19 syndrome
Conditions
Interventions
Group 1: The cases of the patients in the intervention group are discussed in a virtual case conference by general practitioners, public health physicians and employees of the job center/employment ag
Sponsors
Deutsche Rentenversicherung Hessen
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: In total 4 weeks of incapacity to work in the last 6 month due to musculoskeletal, oncological or psychological diseases or post-COVID-19 syndrome; High risk of permanent incapacity to work (moderate or critical work ability as measured by the Work Ability Index (= 36 points)).
Exclusion criteria
Exclusion criteria: Primary diagnosis of an addiction disorder or traumatic brain injury, current application for rehabilitation; an old-age or reduced earning capacity pension is being drawn or a corresponding application has been made; civil servant or person equivalent to a civil servant with pension entitlements; persons with private health insurance; persons permanently retired from working life; habitual residence abroad; limited ability to communicate in German (unable to understand the study and/or complete questionnaires); acute illnesses, which make participation in the rehabilitation measures impossible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction in the cumulative incapacity to work within one year after the expected completion of treatment (< 34 days) in the intervention group compared to the control group (health insurance data). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. A reduction in the cumulative incapacity to work within one year after the expected completion of treatment in the intervention group compared to the control group (patient self-report). 2. An increase in work ability as measured by the Work Ability Index in the intervention group compared to the control group one year after the expected completion of treatments. 3. An improvement in health-related quality of life as measured by the SF-36 in the intervention group compared to the control group one year after the expected completion of treatments. 4. An evaluation of the implementation of the intervention and the mechanisms of effectiveness (process evaluation with qualitative interviews). Update (03/2024): Due to the early termination (12/2023) of the randomised study due to the low recruitment numbers, no quantitative evaluation of results is possible. A qualitative process evaluation (see point 4.) was carried out to evaluate the realisation of the intervention and to identify factors and mechanisms for successful implementation in the context of primary care. | — |
Countries
Germany
Contacts
Public ContactKristina Buch
Philipps-Universität Marburg, Institut für Allgemeinmedizin
Outcome results
None listed